Defining the Molecular Signature of Lipedema as a Biomarker and Potential Therapeutic Target

Work toward defining a molecular signature of lipedema, with potential use as a diagnostic biomarker and a therapeutic target.

Speaker: Tara Karnezis, PhD (Australia)

Recorded at the Boston Lymphatic Symposium 2026, Clinical Symposium Day 1, Thursday, February 19, 2026, at Merck Laboratories in Boston, MA.